Investigations on the countering of stressful metabolic TMEs have also demonstrated that peroxisome proliferator activated receptor alpha (PPARα) agonists increase the efficacy of adenovirus chimpanzee (AdC68)-based melanoma cancer vaccines by allowing TILs to access glucose, thus increasing their ability to kill cancer cells [242]. This evidence concerns the gene PPARA and cancer.